SeaStar Medical Holding ICU
NASDAQ ICU
$4.69 +0.94 (+25.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

SeaStar Medical Holding (ICU) Return on Equity [ROE] (2025 - 2026)

Updated

SeaStar Medical Holding's Return on Equity [ROE] was -234.73% in Q2 2026, up 519.04 percentage points from -753.76% a year earlier but down 100.51 percentage points from the prior quarter.

Analysis

SeaStar Medical Holding (ICU) Return on Equity [ROE] (2025 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at SeaStar Medical Holding came in at -295.15%.

  • Quarterly Return on Equity [ROE] has moved between -753.76% (Q2 2025) and -111.32% (Q4 2025) over five years.
  • Per Business Quant data, ICU's Return on Equity [ROE] in the three quarters before Q2 2026 was -134.22% (Q1 2026), -111.32% (Q4 2025) and -184.98% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 13.36%
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 10.39%
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 7.56%
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 17.60%
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 10.44%
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn -3.90%
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 14.31%
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 9.53%
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 3.88%
10 SeaStar Medical Holding 19.98 Mn -22.15 Mn 561,000.00 -234.73%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -234.73%
Mar 31, 2026 -134.22%
Dec 31, 2025 -111.32%
Sep 30, 2025 -184.98%
Jun 30, 2025 -753.76%
API Access

SeaStar Medical Holding Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ICU&period=max&api_key=YOUR_API_KEY